Edinburgh Research Explorer

Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis

Research output: Contribution to journalArticlepeer-review

Standard

Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis. / Lemos, Henrique; Mohamed, Eslam; Ou, Rong; McCardle, Caroline; Zheng, Xiaozhong; McGuire, Kris; Homer, Natalie Z M; Mole, Damian J; Huang, Lei; Mellor, Andrew L.

In: Frontiers in Immunology, Vol. 11, 17.06.2020, p. 1256.

Research output: Contribution to journalArticlepeer-review

Harvard

Lemos, H, Mohamed, E, Ou, R, McCardle, C, Zheng, X, McGuire, K, Homer, NZM, Mole, DJ, Huang, L & Mellor, AL 2020, 'Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis', Frontiers in Immunology, vol. 11, pp. 1256. https://doi.org/10.3389/fimmu.2020.01256

APA

Lemos, H., Mohamed, E., Ou, R., McCardle, C., Zheng, X., McGuire, K., Homer, N. Z. M., Mole, D. J., Huang, L., & Mellor, A. L. (2020). Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis. Frontiers in Immunology, 11, 1256. https://doi.org/10.3389/fimmu.2020.01256

Vancouver

Lemos H, Mohamed E, Ou R, McCardle C, Zheng X, McGuire K et al. Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis. Frontiers in Immunology. 2020 Jun 17;11:1256. https://doi.org/10.3389/fimmu.2020.01256

Author

Lemos, Henrique ; Mohamed, Eslam ; Ou, Rong ; McCardle, Caroline ; Zheng, Xiaozhong ; McGuire, Kris ; Homer, Natalie Z M ; Mole, Damian J ; Huang, Lei ; Mellor, Andrew L. / Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis. In: Frontiers in Immunology. 2020 ; Vol. 11. pp. 1256.